Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia.
Heather C MurrayAnoop K EnjetiRichard G S KahlHayley M FlanaganJonathan SillarDavid A Skerrett-ByrneJuhura G Al MaziGough G AuCharles E de BockKathryn EvansNathan D SmithAmanda AndersonBrett NixonRichard B LockMartin R LarsenNicole M VerrillsMatthew D DunPublished in: Leukemia (2020)